Kabra Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 21, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	638	263	32	24	20	20	Upgrade
Market Cap Growth	2458.41%	732.49%	29.08%	22.42%	0.89%	43.63%	Upgrade
Enterprise Value	525	248	48	36	29	26	Upgrade
Last Close Price	26.90	11.08	7.19	5.57	4.55	4.51	Upgrade
PE Ratio	43.36	-	-	-	-	-	Upgrade
PS Ratio	2.37	-	-	-	-	-	Upgrade
PB Ratio	2.45	1.07	2.91	-3.34	-5.08	-9.53	Upgrade
P/TBV Ratio	2.45	1.07	2.91	-	-	-	Upgrade
EV/Sales Ratio	1.95	-	-	-	-	-	Upgrade
EV/EBITDA Ratio	70.14	-	-	-	-	-	Upgrade
EV/EBIT Ratio	72.28	-	-	-	-	-	Upgrade
EV/FCF Ratio	-4.59	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.02	0.02	1.58	-1.89	-2.61	-4.33	Upgrade
Debt / EBITDA Ratio	0.63	-	-	-	-	-	Upgrade
Asset Turnover	0.91	-	-	-	-	-	Upgrade
Quick Ratio	1.13	38.24	0.95	0.42	0.54	0.79	Upgrade
Current Ratio	1.87	43.84	1.30	0.47	0.63	0.85	Upgrade
Return on Equity (ROE)	8.16%	-8.44%	-418.41%	-	-	-	Upgrade
Return on Assets (ROA)	1.53%	-7.24%	-17.44%	-30.03%	-10.80%	-7.94%	Upgrade
Return on Invested Capital (ROIC)	5.99%	-90.19%	-203.14%	-53.82%	-28.03%	-27.58%	Upgrade
Return on Capital Employed (ROCE)	2.80%	-7.00%	-68.00%	47.10%	46.90%	86.10%	Upgrade
Earnings Yield	1.87%	-4.13%	-23.33%	-13.82%	-9.29%	-9.10%	Upgrade
FCF Yield	-17.95%	-18.11%	-6.61%	-14.50%	-6.70%	-12.59%	Upgrade
Buyback Yield / Dilution	-617.12%	-149.01%	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.